id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-289533-hip9qtu5	Smulever, Anabella	Thyroid cancer in the Era of COVID-19	2020-08-04		.txt	text/plain	2822	130	41	Since this disease is considered an immunosuppressive status by itself, especially in some types of cancer, the medical community has become increasingly concerned about the potentially deleterious effects that COVID-19 infection may cause in these patients. However, the limited current medical evidence suggests that there is no reason to believe that merely a history of thyroid cancer is enough to have an increased risk of developing COVID-19 infection or to evolve into a poor outcome. The frequency and modality of surveillance for patients with thyroid cancer in the COVID-19 pandemic must be adapted according to the risk of recurrence and the response to treatment. Patients with an excellent, indeterminate, or biochemical incomplete response to treatment do not constitute a risk group for COVID-19 infection, and the frequency of structural disease is less than 4%, 15%, and 20%, respectively [14] .	./cache/cord-289533-hip9qtu5.txt	./txt/cord-289533-hip9qtu5.txt